Companies / hengdi-pharmaceutical-co-ltd-301211

Hengdi Pharmaceutical Co., Ltd. (301211)

ChinaTechnology & Electronics

Overview

Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China and internationally. It is involved in the research and development, production, and sales of chemical raw materials and preparations; and provision of contract research and development, and production services. The company also provides raw material products, including non-steroidal anti-inflammatory raw materials ibuprofen and dexibuprofen, cardiovascular raw material

Employees952
Market Cap$4.0B
Revenue$459.0M
Listed OnShenzhen Stock Exchange
Ticker301211
CEOMr. Qun Liang
HeadquartersJingmen

Website

https://www.biocause.com